$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016

Published by Global Data: 31 Aug 2016 | 27395 | In Stock

Introduction

Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Muckle-Wells Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Muckle-Wells Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 3

    Report Guidance 4

    Clinical Trials by Region 5

    Clinical Trials and Average Enrollment by Country 6

    Top Countries Contributing to Clinical Trials in Asia-Pacific 8

    Top Five Countries Contributing to Clinical Trials in Europe 9

    Top Countries Contributing to Clinical Trials in North America 10

    Top Countries Contributing to Clinical Trials in Middle East and Africa 11

    Top Countries Contributing to Clinical Trials in Central and South America 12

    Clinical Trials by G7 Countries: Proportion of Muckle-Wells Syndrome to Genetic Disorders Clinical Trials 13

    Clinical Trials by Phase in G7 Countries 14

    Clinical Trials in G7 Countries by Trial Status 15

    Clinical Trials by E7 Countries: Proportion of Muckle-Wells Syndrome to Genetic Disorders Clinical Trials 16

    Clinical Trials by Phase in E7 Countries 17

    Clinical Trials by Phase 18

    Clinical Trials by Trial Status 19

    Clinical Trials by End Point Status 20

    Subjects Recruited Over a Period of Time 21

    Clinical Trials by Sponsor Type 22

    Prominent Sponsors 23

    Top Companies Participating in Muckle-Wells Syndrome Therapeutics Clinical Trials 24

    Clinical Trial Profile Snapshots 25

    Appendix 36

    Abbreviations 36

    Definitions 36

    Research Methodology 37

    Secondary Research 37

    About GlobalData 38

    Contact Us 38

    Disclaimer 38

    Source 39

List Of Tables
in Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016

List of Tables

Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Region, 2016* 5

Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Muckle-Wells Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8

Muckle-Wells Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9

Muckle-Wells Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2016* 10

Muckle-Wells Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11

Muckle-Wells Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12

Proportion of Muckle-Wells Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 13

Muckle-Wells Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14

Muckle-Wells Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15

Proportion of Muckle-Wells Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2016* 16

Muckle-Wells Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Phase, 2016* 18

Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19

Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20

Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21

Muckle-Wells Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22

Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23

Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24

List Of Figures, Charts and Diagrams
in Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016

List of Figures

Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2016* 5

Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Muckle-Wells Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8

Muckle-Wells Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9

Muckle-Wells Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10

Muckle-Wells Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 11

Muckle-Wells Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 12

Proportion of Muckle-Wells Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 13

Muckle-Wells Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14

Muckle-Wells Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15

Proportion of Muckle-Wells Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2016* 16

Muckle-Wells Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2016* 18

Muckle-Wells Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19

Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20

Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21

Muckle-Wells Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22

Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23

Muckle-Wells Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24

GlobalData Methodology 37

Additional Details

Publisher

Global Data

Publisher Information

Reference

27395 | GDHC3716CTIDB

Number of Pages

39

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Muckle-Wells Syndrome Market: By family of Cryopyrin (Associated periodic syndromes (CAPS), mutation of CIAS1 gene) & By Region-Forecast (2016-2021)
Muckle-Wells Syndrome (MWS) is a rare, genetic autosomal disease which leads to urticaria, sensorine...
08 Jan 2016 by Industry ARC USD $5,250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data